Moreover, Bcl-2 overexpression in glioma [6, 13], neuroblastoma [14], melanoma [15], breast cancer [5], lung cancer [17], and vascular smooth muscle cells [28] increases the expression and activity of MMP-2, MMP-9, and uPA. This evidence concerns the gene BCL2 and central nervous system cancer.